K-V PHARMACEUTICALS CO CL A
KV.A
KV.A was delisted on the 3rd of August, 2012.
0 hedge funds and large institutions have $0 invested in K-V PHARMACEUTICALS CO CL A in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $603K → $0 (-$603K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFBT
Parkside Financial Bank & Trust
Saint Louis,
Missouri
|
-$603K |
KV.A Hedge Fund Activity: Q3 2013 in Review
0 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in K-V PHARMACEUTICALS CO CL A (KV.A) for Q3 2013, worth a combined $0 — down 100% from $603K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of KV.A and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Parkside Financial Bank & Trust, exiting entirely with an estimated $603K sold.
- 0 institutional investors held K-V PHARMACEUTICALS CO CL A (KV.A) as of Q3 2013, down from 1 in Q2 2013.
- Funds reported $0 of K-V PHARMACEUTICALS CO CL A stock for Q3 2013, down 100% quarter-over-quarter.
- 0 funds opened new K-V PHARMACEUTICALS CO CL A positions in Q3 2013 and 1 closed out, a net change of -1 holder.
- The largest K-V PHARMACEUTICALS CO CL A seller in Q3 2013 was Parkside Financial Bank & Trust, an estimated $603K sold.
Based on aggregated 13F filings for Q3 2013.